Andecaliximab Biosimilar Monoclonal Antibody (MMP-9) for Research

Cat No.: GMP-Bios-ab-024

Pre-Made Andecaliximab biosimilar, Whole mAb, Anti-MMP9/MMP-9 Antibody: Anti-CLG4B/GELB/MANDP2 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Andecaliximab (INN; development code GS-5745) is an experimental humanized monoclonal antibody designed for the treatment of cancer and inflammatory diseases.

Order Information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-024-1mg 1mg 618

Size: 1mg | 10mg | 100mg



Product Details

Products Name (INN Index) Pre-Made Andecaliximab biosimilar, Whole mAb, Anti-MMP9/MMP-9 Antibody: Anti-CLG4B/GELB/MANDP2 therapeutic antibody
INN Name Andecaliximab
TargetMMP-9
FormatWhole mAb
DerivationChimeric (Mouse/Human)
Species ReactivityHuman
CH1 IsotypeIgG4
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-III
Est. StatusDiscontinued
100% SI Structure5th9:HL:IM:JN
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2016
Year Recommended2017
CompaniesGilead Sciences
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedChronic obstructive pulmonary disease;Crohn's disease;Cystic fibrosis;Rheumatoid arthritis;Ulcerative colitis;Gastric cancer;Solid tumours;Glioblastoma
Development Techna



About target - MMP9

1. Protein Matrix metalloproteinase-9

2. Gene MMP9

3. Organism Homo sapiens (Human)

Function

Matrix metalloproteinase that plays an essential role in local proteolysis of the extracellular matrix and in leukocyte migration (PubMed:2551898, PubMed:1480034, PubMed:12879005).

Could play a role in bone osteoclastic resorption (By similarity).

Cleaves KiSS1 at a Gly-|-Leu bond (PubMed:12879005).

Cleaves NINJ1 to generate the Secreted ninjurin-1 form (PubMed:32883094).

Cleaves type IV and type V collagen into large C-terminal three quarter fragments and shorter N-terminal one quarter fragments (PubMed:1480034).

Degrades fibronectin but not laminin or Pz-peptide.

Miscellaneous

In the arthritis patient this enzyme might contribute to the pathogenesis of joint destruction and might constitute a useful marker of disease status.

Catalytic activityi

Cleavage of gelatin types I and V and collagen types IV and V. EC:3.4.24.35

Cofactor

Protein has several cofactor binding sites:

Zn2+

Note: Binds 2 Zn2+ ions per subunit.

Ca2+

Note: Binds 3 Ca2+ ions per subunit.

Activity regulationi

Inhibited by histatin-3 1/24 (histatin-5). Inhibited by ECM1.